ロード中...
Behavioral and Cellular Pharmacology Characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3′-carboxamido)morphinan (NAQ) as a Mu Opioid Receptor Selective Ligand
Mu opioid receptor (MOR) selective antagonists and partial agonists have been used for the treatment of opioid abuse and addiction. Our recent efforts on the identification of MOR antagonists have provided several novel leads displaying interesting pharmacological profiles. Among them, 17-cyclopropy...
保存先:
主要な著者: | , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
2014
|
主題: | |
オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4073486/ https://ncbi.nlm.nih.gov/pubmed/24815322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2014.04.041 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|